Surolan vet.

1 x 15 ml

Ear drops/cutaneous suspension

Active substance

Miconazole (Miconazole nitrate) : 23 mg/ml

Prednisolone (Prednisolone actetate) : 5 mg/ml

Polymyxin B (Polymyxin B-sulfate) : 0,5293 mg/ml

ATC code

QS02CA01 Prednisolone (Corticosteroids - weak (group I)) and antiinfectives

QS02CA Corticosteroids and antiinfectives in comb.

QS02C Corticosteroids and antiinfectives in comb.

QS02 Otologicals

QS Sensory organs

Species

Dogs and cats

Indications

For the topical treatment of otitis externa and skin infections caused by Grampositive bacteria e.g. Staphylococcus aureus and Streptococcus spp. and Gramnegative bacteria Escherichia coli and Pseudomonas aeruginosa.

For the topical treatment of otitis externa and skin infections caused by fungi and yeasts: Trichophyton spp., Microsporum spp., Malassezia pachydermatis, Candida spp.

For the topical treatment of otitis externa caused by the ear mite Otodectes cynotis.

The product also has anti-inflammatory and anti-pruritic activity.

Dose to be administered and administration route

This product is for topical administration. Shake the bottle vigorously and ensure the product is fully resuspended before use.

At the beginning of treatment, hair surrounding or covering the lesions must be clipped; this should be repeated during treatment if necessary.

Ears: Clean the auditory canal and place a few drops of the product into the ear twice daily. For infections caused by Otodectes cynotis, instill five drops twice daily for 14 days.

Massage the ear and the auditory canal gently but thoroughly to ensure proper distribution.

Skin: Having ensured the area to be treated is clean, apply a few drops of the product (depending on lesion size) twice a day and rub well.

Treatment should be continued until a few days after complete disappearance of the clinical symptoms. In some obstinate cases, treatment may be required for 2 to 3 weeks (see also 4.6).

Where ear mite infestation is present, consideration should be given to treating both ears even if infestation is only apparent in one ear.

Adverse reactions

Dogs and cats:

Very rare

(< 1 animal / 10,000 animals treated, including isolated reports):

Deafness¹

Impaired hearing¹

¹Mainly in elderly dogs. If this occurs, treatment should be stopped. Decreased hearing or deafness is generally temporary in nature.

Prolonged use of topical steroids can cause skin discoloration and delay wound healing.

The conventional adverse effects of corticosteroids can occur (disturbance of biochemical parameters, such as increased cortisol and hepatic enzyme levels).

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See also the last section of the package leaflet for contact details.